Science historian predicts one billion deaths from tobacco by end of century

November 29, 2001

University Park, Pa. --In the October issue of the journal Nature Cancer Reviews, Penn State science historian Robert Proctor predicts that, left unchecked, tobacco products will cause up to one billion deaths by the end of the 21st century.

Proctor's prediction is the result of his historical analysis of how many cigarettes it takes to produce a given level of mortality, plus an analysis of global smoking rates and trends. He shows that lung cancer was an extraordinarily rare disease before the 20th century, so rare that physicians were astonished whenever they saw a case. It was not even medically described until the 18th century and, for many years thereafter, was notoriously difficult to diagnose. A Penn State distinguished professor of history and co-director, Science, Medicine and Technology in Culture Initiative, he points out the direct correlation in the rise in incidences of lung cancer and the rise in the number of smokers.

Lung cancer was first linked to cigarettes in 1912 by physician and pathologist Isaac Adler, and several other medical professionals reasserted the link in subsequent years. However, the first formal quantitative analysis of the link did not occur until 1929, in Dresden, Germany. That same year, global cigarette consumption was already at around 600 billion cigarettes per year. It would rise to 10 times that amount by its peak in 1990. In his article, Proctor traces the medical research advances by which lung cancer was linked to cigarettes, the global spread of tobacco usage, the political obstacles to tobacco control, and the growth in cancer rates worldwide.

As a result, Proctor is able to present statistics showing there is about one lung cancer death for every 3 million cigarettes consumed. An important component to that statistic, he says, is that "cigarette smoke is unlike radon, asbestos, aniline dye or most other carcinogens in that the dosages delivered to the body are remarkably uniform. Cigarettes are pretty much the same size and composition throughout the world, as are the routes by which the body is exposed. And as consumption rates are carefully recorded by governments (primarily for taxation purposes), it is fairly easy to predict the long-term cancer consequences of a given level of consumption."

The Penn State science historian has published extensively on the health and cultural effects of tobacco and other controversial killers, in his books "Cancer Wars: How Politics Shapes What We Know and Don't Know About Cancer," "The Nazi War on Cancer" and "Racial Hygiene: Medicine Under the Nazis," as well as in numerous articles.

Penn State

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to